Basal Ganglia Pathophysiology
141 – 150 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Congo red and protein aggregation in neurodegenerative diseases
- Contribution to journal › Article
-
Mark
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
- Contribution to journal › Article
-
Mark
Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model.
- Contribution to journal › Scientific review
-
Mark
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with l-DOPA: Relation to dose and route of administration.
- Contribution to journal › Article
-
Mark
Animal models of neurodegenerative disease: Insights from in vivo imaging studies
- Contribution to journal › Scientific review
-
Mark
Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
- Contribution to journal › Article
-
Mark
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
- Contribution to journal › Article
-
Mark
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.
(2007) In Current protocols in neuroscience / editorial board, Jacqueline N. Crawley ... [et al.] Chapter 9(Oct). p.9-25
- Contribution to journal › Article
